RFP
ANIP icon

Root Financial Partners’s ANI Pharmaceuticals ANIP Stock Holding History

Root Financial Partners’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6
Closed -$461 – 555
2026
Q1 		$461 Buy
+6
New +$468 ﹤0.01% 2895

Other funds holding ANIP

MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
MUAMU
Mitsubishi UFJ Asset Management (UK) London, United Kingdom $215M AUM 47.21% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Root Financial Partners's ANIP Position: Q2 2026 in Review

Root Financial Partners sold out of ANI Pharmaceuticals (ANIP) in Q2 2026, closing a stake of 6 shares — an estimated $461 sold.

Root Financial Partners first reported a position in ANIP in Q1 2026 and held it in 1 quarter. The position peaked at $461 in Q1 2026. 53 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Root Financial Partners reported no remaining ANI Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 6 ANI Pharmaceuticals shares in Q2 2026, an estimated $461.
  • Root Financial Partners first reported a position in ANI Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Root Financial Partners's ANI Pharmaceuticals position peaked at $461 in Q1 2026.
  • 53 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.